Juniper Biologics
Manufacturing · Thailand · 11-50 Employees
View Company Info for Free
Overview
Headquarters
175 S Sathorn Road Thungmahamek Sathorn,...Phone Number
+65 69087578Website
www.juniperbiologics.comRevenue
$6.7 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Juniper Biologics
Juniper Biologics is a leading science-driven pharmaceutical company dedicated to researching, developing, and commercializing innovative therapies. The company focuses on areas such as oncology, rare diseases, and gene therapy, aiming to make advanced medicine accessible to those in need. With a global headquarters in Singapore, Juniper Biologics has received multiple awards for its contributions to healthcare innovation. Their intended clients include patients requiring novel treatments and healthcare providers seeking effective therapeutic solutions.Explore more
Juniper Biologics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Juniper Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Juniper Biologics is spiking on competitors!
Earning: See what the market has to say on Juniper Biologics recently announced quarterly report
Check if Juniper Biologics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Juniper Biologics launches new products
Click to see if Juniper Biologics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Juniper Biologics
Juniper Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Juniper Biologics has new funding data
Recommended Actions
Find VP level buyers at Juniper Biologics
Find more new buyers
Company Profile Activity
Activity Insights
Juniper Biologics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Juniper Biologics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Juniper Biologics.
Juniper Biologics Tech Stack
A closer look at the technologies used by Juniper Biologics
See more technologies
Juniper Biologics News & Media
Juniper Biologics Named "Pharmaceutical Company of the Year" at Corporate LiveWire Global Awards
SINGAPORE, April 22, 2024 /PRNewswire/ -- Juniper Biologics ("Juniper"), a global science-led pharmaceutical company dedicated to advancing treatments in specialised therapy areas, has been named "Pharmaceutical Company of the Year" by the Corporate LiveWire Global Awards for the year 2023-2024. The Corporate LiveWire Global Awards spotlight the outstanding achievements and contributions of top professionals and companies who have demonstrated excellence, innovation, and a commitment to exceptioJuniper Biologics Named "Pharmaceutical Company of the Year" at Corporate LiveWire Global Awards
SINGAPORE, April 22, 2024 /PRNewswire/ -- Juniper Biologics ("Juniper"), a global science-led pharmaceutical company dedicated to advancing treatments in specialised therapy areas, has been named "Pharmaceutical Company of the Year" by the Corporate LiveWire Global Awards for the year 2023-2024. The Corporate LiveWire Global Awards spotlight the outstanding achievements and contributions of top professionals and companies who have demonstrated excellence, innovation, and a commitment to exceptioAdvancing Healthcare Innovation: Juniper Biologics Recognized as the Best Novel Therapy R&D and Commercialization Company 2024 by APAC Insider
SINGAPORE, March 25, 2024 /PRNewswire/ -- Juniper Biologics ("Juniper"), Singapore-based science-led pharmaceutical company focused on researching, developing, and commercializing novel therapies, celebrates another milestone as it received the award for Best Novel Therapy R&D and Commercialization Company at the APAC Insider Singapore Business Awards 2024. The APAC Insider Singapore Business Awards serves to spotlight companies and entrepreneurs driving growth in the region's business market anSingapore-based Juniper Biologics Awarded the Most Innovative Oncology Pharmaceutical Company 2023 by GHP Healthcare and Pharmaceutical Awards
SINGAPORE, Oct. 24, 2023 /PRNewswire/ -- Juniper Biologics, a global science-led pharmaceutical company headquartered in Singapore, has been honored with the prestigious title of the "Most Innovative Oncology Pharmaceutical Company 2023" by the Global Health & Pharma (GHP) Healthcare and Pharmaceutical Awards. This recognition underscores Juniper Biologics' commitment to advancing healthcare by delivering groundbreaking therapies in the field of Oncology and oncology-supportive care. The annual
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Juniper Biologics
Sign Up For FreeTo access detailed company insights
Juniper Biologics is a leading science-driven pharmaceutical company dedicated to researching, developing, and commercializing innovative therapies. The company focuses on areas such as oncology, rare diseases, and gene therapy, aiming to make advanced medicine accessible to those in need. With a global headquarters in Singapore, Juniper Biologics... Read More
